Diabetes has emerged as a major economic burden with high associated human and financial cost. It a chronic disease affecting millions of population globally every year. Insulin is administered to the diabetic patient using various insulin delivery devices; out of these insulin pen is the most preferred option. The report “Global Insulin Market – Focus on Insulin Delivery Devices Market Outlook 2022” provides an in-depth analysis of global insulin therapy market, focusing on insulin delivery devices such as vial and syringes, insulin pen, insulin pump, etc.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities at the global and regional level. The report has been segmented as following:-

Market Segmentation
• Insulin Market
• Insulin Delivery Devices Market
Market Segmentation by Geography
• Europe
• North America and Caribbean
• China
Key Vendors
• Novo Nordisk
• Sanofi Aventis
• Eli Lilly and Company
• Merck and Company